X
DFTX

Xponance’s Definium Therapeutics DFTX Stock Holding History

Xponance’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$598K Buy
+12,716
New +$314K ﹤0.01% 1016
2022
Q2 		– Sell
-1,015
Closed -$17K – 1214
2022
Q1 		$17K Sell
1,015
-84
-8% -$1.46K ﹤0.01% 1158
2021
Q4 		$23K Buy
1,099
+8
+0.7% +$255 ﹤0.01% 1163
2021
Q3 		$38K Sell
1,091
-84
-7% -$3.63K ﹤0.01% 1159
2021
Q2 		$61K Buy
+1,175
New +$61.7K ﹤0.01% 1227

Other funds holding DFTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Xponance's DFTX Position: Q2 2026 in Review

Xponance opened a new position in Definium Therapeutics (DFTX) in Q2 2026: 12,716 shares worth $598K. The stake represents ﹤0.01% of the portfolio and ranks #1016 among its holdings. This is a return to the name: Xponance previously reported a position in DFTX as recently as Q1 2022.

Xponance first reported a position in DFTX in Q2 2021 and has held it in 5 quarters since. 362 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

  • Xponance held 12,716 shares of Definium Therapeutics worth $598K as of Q2 2026.
  • Definium Therapeutics was a new Xponance position in Q2 2026.
  • Definium Therapeutics made up ﹤0.01% of Xponance's portfolio in Q2 2026, its #1016 holding.
  • Xponance first reported a position in Definium Therapeutics in Q2 2021 and has held it in 5 quarters since.
  • 362 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.